The DOI matches its Crossref record; 138 of the 138 references it cites were found in a registry or an index.
Chronic myeloid leukaemia as a model of disease evolution in human cancer
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Specific Association of Human Telomerase Activity with Immortal Cells and Cancer
Kim, N. W., Piatyszek, M. A., Prowse, K. R., Harley, C. B., West, M. D., Ho, P. L. C., Coviello, G. M., Wright, W. E., Weinrich, S. L., & Shay, J. W. (1994) · Science · doi:10.1126/science.7605428 · Cited by 7,091 · cited 1×
“Paradoxically, telomerase activity has been described as being upregulated in many human cancers, and active telomerase is thought to be essential for the immortalization of malignant cell”
BackgroundA Gene-Expression Signature as a Predictor of Survival in Breast Cancer
van de Vijver, M. J., He, Y. D., van 't Veer, L. J., Dai, H., Hart, A. A. M., Voskuil, D. W., Schreiber, G. J., Peterse, J. L., Roberts, C., Marton, M. J., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa021967 · Cited by 6,488
A Strong Candidate for the Breast and Ovarian Cancer Susceptibility Gene BRCA1
Miki, Y., Swensen, J., Shattuck-Eidens, D., Futreal, P. A., Harshman, K., Tavtigian, S., Liu, Q., Cochran, C., Bennett, L. M., Ding, W., et al. (1994) · Science · doi:10.1126/science.7545954 · Cited by 6,071
Druker, B. J., Talpaz, M., Resta, D. J., Peng, B., Buchdunger, E., Ford, J. M., Lydon, N. B., Kantarjian, H., Capdeville, R., Ohno-Jones, S., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200104053441401 · Cited by 5,243
ROWLEY, J. D. (1973) · Nature · doi:10.1038/243290a0 · Cited by 4,291
Genome maintenance mechanisms for preventing cancer
Hoeijmakers, J. H. J. (2001) · Nature · doi:10.1038/35077232 · Cited by 3,939
A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4.
Serrano, M., Hannon, G. J., & Beach, D. (1993) · Nature · doi:10.1038/366704a0 · Cited by 3,650
Five-Year Follow-up of Patients Receiving Imatinib for Chronic Myeloid Leukemia
Druker, B. J., Guilhot, F., O'Brien, S. G., Gathmann, I., Kantarjian, H., Gattermann, N., Deininger, M. W. N., Silver, R. T., Goldman, J. M., Stone, R. M., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa062867 · Cited by 3,488
Effects of a selective inhibitor of the Abl tyrosine kinase on the growth of Bcr-Abl positive cells
Druker, B. J., Tamura, S., Buchdunger, E., Ohno, S., Segal, G. M., Fanning, S., Zimmermann, J., & Lydon, N. B. (1996) · Nature Medicine · doi:10.1038/nm0596-561 · Cited by 2,967
Constitutive Transcriptional Activation by a β-Catenin-Tcf Complex in APC −/− Colon Carcinoma
Korinek, V., Barker, N., Morin, P. J., van Wichen, D., de Weger, R., Kinzler, K. W., Vogelstein, B., & Clevers, H. (1997) · Science · doi:10.1126/science.275.5307.1784 · Cited by 2,905
Paik, S., Tang, G., Shak, S., Kim, C., Baker, J., Kim, W., Cronin, M., Baehner, F. L., Watson, D., Bryant, J., et al. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.04.7985 · Cited by 2,579
DNA double-strand breaks: signaling, repair and the cancer connection
Khanna, K. K., & Jackson, S. P. (2001) · Nature Genetics · doi:10.1038/85798 · Cited by 2,455
A minute chromosome in human chronic granulocytic leukemia
Nowell̀, P. C. (1960) · Science · Cited by 2,269
Wnt proteins are lipid-modified and can act as stem cell growth factors
Willert, K., Brown, J. D., Danenberg, E., Duncan, A. W., Weissman, I. L., Reya, T., Yates, J. R., & Nusse, R. (2003) · Nature · doi:10.1038/nature01611 · Cited by 2,257
A role for Wnt signalling in self-renewal of haematopoietic stem cells
Reya, T., Duncan, A. W., Ailles, L., Domen, J., Scherer, D. C., Willert, K., Hintz, L., Nusse, R., & Weissman, I. L. (2003) · Nature · doi:10.1038/nature01593 · Cited by 2,159
Dasatinib in imatinib-resistant Philadelphia chromosome-positive leukemias
Talpaz, M., Shah, N. P., Kantarjian, H., Donato, N., Nicoll, J., Paquette, R., Cortes, J., O'Brien, S., Nicaise, C., Bleickardt, E., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa055229 · Cited by 1,760
Daley, G. Q., Van Etten, R. A., & Baltimore, D. (1990) · Science · doi:10.1126/science.2406902 · Cited by 1,756
The molecular biology of chronic myeloid leukemia
Deininger, M. W. N., Goldman, J. M., & Melo, J. V. (2000) · Blood · doi:10.1182/blood.v96.10.3343 · Cited by 1,667
Self-citationTelomere reduction in human colorectal carcinoma and with ageing
Hastie, N. D., Dempster, M., Dunlop, M. G., Thompson, A. M., Green, D. K., & Allshire, R. C. (1990) · Nature · doi:10.1038/346866a0 · Cited by 1,650
Philadelphia chromosomal breakpoints are clustered within a limited region, bcr, on chromosome 22
GROFFEN, J., STEPHENSON, J., HEISTERKAMP, N., DEKLEIN, A., BARTRAM, C., & GROSVELD, G. (1984) · Cell · doi:10.1016/0092-8674(84)90077-1 · Cited by 1,599
Pomerantz, J., Schreiber-Agus, N., Liégeois, N. J., Silverman, A., Alland, L., Chin, L., Potes, J., Chen, K., Orlow, I., Lee, H.-W., et al. (1998) · Cell · doi:10.1016/s0092-8674(00)81400-2 · Cited by 1,521
Chk1 and Chk2 kinases in checkpoint control and cancer
Bartek, J., & Lukas, J. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00110-7 · Cited by 1,513
Granulocyte-macrophage progenitors as candidate leukemic stem cells in blast-crisis CML
Jamieson, C. H. M., Ailles, L. E., Dylla, S. J., Muijtjens, M., Jones, C., Zehnder, J. L., Gotlib, J., Li, K., Manz, M. G., Keating, A., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa040258 · Cited by 1,485
Nilotinib in Imatinib-Resistant CML and Philadelphia Chromosome–Positive ALL
Kantarjian, H., Giles, F., Wunderle, L., Bhalla, K., O'Brien, S., Wassmann, B., Tanaka, C., Manley, P., Rae, P., Mietlowski, W., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa055104 · Cited by 1,344
Tyrosine Kinase Activity and Transformation Potency of bcr-abl Oncogene Products
Lugo, T. G., Pendergast, A.-M., Muller, A. J., & Witte, O. N. (1990) · Science · doi:10.1126/science.2408149 · Cited by 1,281
Wang, Y., Cortez, D., Yazdi, P., Neff, N., Elledge, S. J., & Qin, J. (2000) · Genes & Development · doi:10.1101/gad.14.8.927 · Cited by 1,221
Hughes, T. P., Kaeda, J., Branford, S., Rudzki, Z., Hochhaus, A., Hensley, M. L., Gathmann, I., Bolton, A. E., van Hoomissen, I. C., Goldman, J. M., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa030513 · Cited by 1,218
Graham, S. M., Jørgensen, H. G., Allan, E., Pearson, C., Alcorn, M. J., Richmond, L., & Holyoake, T. L. (2002) · Blood · doi:10.1182/blood.v99.1.319 · Cited by 1,181
Stott, F. J. (1998) · The EMBO Journal · doi:10.1093/emboj/17.17.5001 · Cited by 1,167
Molecular mechanism of nucleotide excision repair
de Laat, W. L., Jaspers, N. G. J., & Hoeijmakers, J. H. J. (1999) · Genes & Development · doi:10.1101/gad.13.7.768 · Cited by 1,122
The Regulation of INK4/ARF in Cancer and Aging
Kim, W. Y., & Sharpless, N. E. (2006) · Cell · doi:10.1016/j.cell.2006.10.003 · Cited by 1,009
The Myeloproliferative Disorders
Campbell, P. J., & Green, A. R. (2006) · New England Journal of Medicine · doi:10.1056/nejmra063728 · Cited by 915
Zhang, D.-E., Zhang, P., Wang, N.-D., Hetherington, C. J., Darlington, G. J., & Tenen, D. G. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.2.569 · Cited by 910
Pabst, T., Mueller, B. U., Zhang, P., Radomska, H. S., Narravula, S., Schnittger, S., Behre, G., Hiddemann, W., & Tenen, D. G. (2001) · Nature Genetics · doi:10.1038/85820 · Cited by 901
Regulation of the INK4b–ARF–INK4a tumour suppressor locus: all for one or one for all
Gil, J., & Peters, G. (2006) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1987 · Cited by 843
Mammalian DNA nucleotide excision repair reconstituted with purified protein components
Aboussekhra, A., Biggerstaff, M., Shivji, M. K. K., Vilpo, J. A., Moncollin, V., Podust, V. N., Protić, M., Hübscher, U., Egly, J.-M., & Wood, R. D. (1995) · Cell · doi:10.1016/0092-8674(95)90289-9 · Cited by 837
Dynamics of chronic myeloid leukaemia
Michor, F., Hughes, T. P., Iwasa, Y., Branford, S., Shah, N. P., Sawyers, C. L., & Nowak, M. A. (2005) · Nature · doi:10.1038/nature03669 · Cited by 833
Loeb, L. A., Loeb, K. R., & Anderson, J. P. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0334858100 · Cited by 762
Bartram, C. R., de Klein, A., Hagemeijer, A., van Agthoven, T., van Kessel, A. G., Bootsma, D., Grosveld, G., Ferguson-Smith, M. A., Davies, T., Stone, M., et al. (1983) · Nature · doi:10.1038/306277a0 · Cited by 747
Risch, H. A., McLaughlin, J. R., Cole, D. E. C., Rosen, B., Bradley, L., Fan, I., Tang, J., Li, S., Zhang, S., Shaw, P. A., et al. (2006) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djj465 · Cited by 680
A Mutator Phenotype in Cancer 1
Loeb, L. A. (2001) · Cited by 670
Stem cell origin of cancer and differentiation therapy
Sell, S. (2004) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2004.04.007 · Cited by 638
Copland, M., Hamilton, A., Elrick, L. J., Baird, J. W., Allan, E. K., Jordanides, N., Barow, M., Mountford, J. C., & Holyoake, T. L. (2006) · Blood · doi:10.1182/blood-2005-07-2947 · Cited by 635
The roles of BRCA1 and BRCA2 and associated proteins in the maintenance of genomic stability
Gudmundsdottir, K., & Ashworth, A. (2006) · Oncogene · doi:10.1038/sj.onc.1209874 · Cited by 622
The biology of CML blast crisis
Calabretta, B., & Perrotti, D. (2004) · Blood · doi:10.1182/blood-2003-12-4111 · Cited by 592
Gene expression changes associated with progression and response in chronic myeloid leukemia
Radich, J. P., Dai, H., Mao, M., Oehler, V., Schelter, J., Druker, B., Sawyers, C., Shah, N., Stock, W., Willman, C. L., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0510423103 · Cited by 583
The INK4A/ARF locus and its two gene products.
Sharpless, N. E., & DePinho, R. A. (1999) · Current Opinion in Genetics & Development · doi:10.1016/s0959-437x(99)80004-5 · Cited by 533
Ilaria, R. L., & Van Etten, R. A. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.49.31704 · Cited by 488
BRCA1 regulates the G2/M checkpoint by activating Chk1 kinase upon DNA damage
Yarden, R. I., Pardo-Reoyo, S., Sgagias, M., Cowan, K. H., & Brody, L. C. (2002) · Nature Genetics · doi:10.1038/ng837 · Cited by 484
Carlesso, N., Frank, D. A., & Griffin, J. D. (1996) · The Journal of experimental medicine · doi:10.1084/jem.183.3.811 · Cited by 483
Neviani, P., Santhanam, R., Trotta, R., Notari, M., Blaser, B. W., Liu, S., Mao, H., Chang, J. S., Galietta, A., Uttam, A., et al. (2005) · Cancer Cell · doi:10.1016/j.ccr.2005.10.015 · Cited by 476
A recurrent mutation in PALB2 in Finnish cancer families
Erkko, H., Xia, B., Nikkilä, J., Schleutker, J., Syrjäkoski, K., Mannermaa, A., Kallioniemi, A., Pylkäs, K., Karppinen, S.-M., Rapakko, K., et al. (2007) · Nature · doi:10.1038/nature05609 · Cited by 466
Alternative splicing of RNAs transcribed from the human abl gene and from the bcr-abl fused gene
Shtivelman, E., Lifshitz, B., Gale, R. P., Roe, B. A., & Canaani, E. (1986) · Cell · doi:10.1016/0092-8674(86)90450-2 · Cited by 464
Cytogenetic and Molecular Genetic Evolution of Chronic Myeloid Leukemia
Johansson, B., Fioretos, T., & Mitelman, F. (2002) · Acta Haematologica · doi:10.1159/000046636 · Cited by 454
Van Etten, R. A., Jackson, P., & Baltimore, D. (1989) · Cell · doi:10.1016/0092-8674(89)90102-5 · Cited by 413
Collis, S. J., DeWeese, T. L., Jeggo, P. A., & Parker, A. R. (2005) · Oncogene · doi:10.1038/sj.onc.1208332 · Cited by 412
McLaughlin, J., Chianese, E., & Witte, O. N. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.18.6558 · Cited by 367
Horita, M., Andreu, E. J., Benito, A., Arbona, C., Sanz, C., Benet, I., Prosper, F., & Fernandez-Luna, J. L. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.191.6.977 · Cited by 366
An ATR- and Cdc7-Dependent DNA Damage Checkpoint that Inhibits Initiation of DNA Replication
Costanzo, V., Shechter, D., Lupardus, P. J., Cimprich, K. A., Gottesman, M., & Gautier, J. (2003) · Molecular Cell · doi:10.1016/s1097-2765(02)00799-2 · Cited by 353
Smith, L., Hohaus, S., Gonzalez, D., Dziennis, S., & Tenen, D. (1996) · Blood · doi:10.1182/blood.v88.4.1234.bloodjournal8841234 · Cited by 332
Matsumura, I. (1999) · The EMBO Journal · doi:10.1093/emboj/18.5.1367 · Cited by 332
Vigneri, P., & Wang, J. Y. J. (2001) · Nature Medicine · doi:10.1038/84683 · Cited by 331
Mitani, K., Ogawa, S., Tanaka, T., Miyoshi, H., Kurokawa, M., Mano, H., Yazaki, Y., Ohki, M., & Hirai, H. (1994) · The EMBO Journal · doi:10.1002/j.1460-2075.1994.tb06288.x · Cited by 325
A critical role for telomeres in suppressing and facilitating carcinogenesis
Artandi, S. E., & DePinho, R. A. (2000) · Current Opinion in Genetics & Development · doi:10.1016/s0959-437x(99)00047-7 · Cited by 318
Amarante-Mendes, G. P., Naekyung Kim, C., Liu, L., Huang, Y., Perkins, C. L., Green, D. R., & Bhalla, K. (1998) · Blood · doi:10.1182/blood.v91.5.1700 · Cited by 316
Activation of the Wnt pathway in non small cell lung cancer: evidence of dishevelled overexpression
Uematsu, K., He, B., You, L., Xu, Z., McCormick, F., & Jablons, D. M. (2003) · Oncogene · doi:10.1038/sj.onc.1206817 · Cited by 314
BCR/ABL Regulates Mammalian RecA Homologs, Resulting in Drug Resistance
Slupianek, A., Schmutte, C., Tombline, G., Nieborowska-Skorska, M., Hoser, G., Nowicki, M. O., Pierce, A. J., Fishel, R., & Skorski, T. (2001) · Molecular Cell · doi:10.1016/s1097-2765(01)00357-4 · Cited by 314
BCR-ABL suppresses C/EBPα expression through inhibitory action of hnRNP E2
Perrotti, D., Cesi, V., Trotta, R., Guerzoni, C., Santilli, G., Campbell, K., Iervolino, A., Condorelli, F., Gambacorti-Passerini, C., Caligiuri, M. A., et al. (2002) · Nature Genetics · doi:10.1038/ng791 · Cited by 313
BCR/ABL kinase induces self-mutagenesis via reactive oxygen species to encode imatinib resistance
Koptyra, M., Falinski, R., Nowicki, M. O., Stoklosa, T., Majsterek, I., Nieborowska-Skorska, M., Blasiak, J., & Skorski, T. (2006) · Blood · doi:10.1182/blood-2005-07-2815 · Cited by 298
Ahuja, H., Bar-Eli, M., Advani, S. H., Benchimol, S., & Cline, M. J. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.17.6783 · Cited by 284
Nowicki, M. O., Falinski, R., Koptyra, M., Slupianek, A., Stoklosa, T., Gloc, E., Nieborowska-Skorska, M., Blasiak, J., & Skorski, T. (2004) · Blood · doi:10.1182/blood-2004-05-1941 · Cited by 278
Holtz, M. S., Slovak, M. L., Zhang, F., Sawyers, C. L., Forman, S. J., & Bhatia, R. (2002) · Blood · doi:10.1182/blood.v99.10.3792 · Cited by 253
Molldrem, J. J., Clave, E., Jiang, Y. Z., Mavroudis, D., Raptis, A., Hensel, N., Agarwala, V., & Barrett, A. J. (1997) · Blood · doi:10.1182/blood.v90.7.2529 · Cited by 234
p53 in chronic myelogenous leukemia in acute phase.
Feinstein, E., Cimino, G., Gale, R. P., Alimena, G., Berthier, R., Kishi, K., Goldman, J., Zaccaria, A., Berrebi, A., & Canaani, E. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.14.6293 · Cited by 220
BCR/ABL activates mdm2 mRNA translation via the La antigen
Trotta, R., Vignudelli, T., Candini, O., Intine, R. V., Pecorari, L., Guerzoni, C., Santilli, G., Byrom, M. W., Goldoni, S., Ford, L. P., et al. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00020-5 · Cited by 217
A murine model of CML blast crisis induced by cooperation between BCR/ABL and NUP98/HOXA9
Dash, A. B., Williams, I. R., Kutok, J. L., Tomasson, M. H., Anastasiadou, E., Lindahl, K., Li, S., Van Etten, R. A., Borrow, J., Housman, D., et al. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.102583199 · Cited by 209
Long-term outcome of treatment of anemia in MDS with erythropoietin and G-CSF
Jädersten, M., Montgomery, S. M., Dybedal, I., Porwit-MacDonald, A., & Hellström-Lindberg, E. (2005) · Blood · doi:10.1182/blood-2004-10-3872 · Cited by 205
A MAPK/HNRPK pathway controls BCR/ABL oncogenic potential by regulating MYC mRNA translation
Notari, M., Neviani, P., Santhanam, R., Blaser, B. W., Chang, J.-S., Galietta, A., Willis, A. E., Roy, D. C., Caligiuri, M. A., Marcucci, G., et al. (2006) · Blood · doi:10.1182/blood-2005-09-3732 · Cited by 202
Griswold, I. J., MacPartlin, M., Bumm, T., Goss, V. L., O'Hare, T., Lee, K. A., Corbin, A. S., Stoffregen, E. P., Smith, C., Johnson, K., et al. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.02202-05 · Cited by 200
Barnes, D. J., Palaiologou, D., Panousopoulou, E., Schultheis, B., Yong, A. S. M., Wong, A., Pattacini, L., Goldman, J. M., & Melo, J. V. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-0076 · Cited by 200
Self-citationBrümmendorf, T. H., Holyoake, T. L., Rufer, N., Barnett, M. J., Schulzer, M., Eaves, C. J., Eaves, A. C., & Lansdorp, P. M. (2000) · Blood · doi:10.1182/blood.v95.6.1883 · Cited by 198
Sill, H., Goldman, J., & Cross, N. (1995) · Blood · doi:10.1182/blood.v85.8.2013.bloodjournal8582013 · Cited by 197
Nucifora, G., Birn, D., Erickson, P., Gao, J., LeBeau, M., Drabkin, H., & Rowley, J. (1993) · Blood · doi:10.1182/blood.v81.4.883.883 · Cited by 196
Wetzler, M., Talpaz, M., Van Etten, R. A., Hirsh-Ginsberg, C., Beran, M., & Kurzrock, R. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116786 · Cited by 188
Clinical significance of phenotypic features of blasts in patients with myelodysplastic syndrome
Ogata, K. (2002) · Blood · doi:10.1182/blood-2002-01-0222 · Cited by 186
Fu, Y., Yu, J., Cheng, T., Lou, M., Hsu, G., Wu, C., Chen, S.-T., Wu, H., Wu, P., & Shen, C. (2003) · PubMed · Cited by 181
Lin, F., van Rhee, F., Goldman, J. M., & Cross, N. C. P. (1996) · Blood · doi:10.1182/blood.v87.10.4473.bloodjournal87104473 · Cited by 179
BCR-ABL down-regulates the DNA repair protein DNA-PKcs
Deutsch, E., Dugray, A., AbdulKarim, B., Marangoni, E., Maggiorella, L., Vaganay, S., M'Kacher, R., Rasy, S. D., Eschwege, F., Vainchenker, W., et al. (2001) · Blood · doi:10.1182/blood.v97.7.2084 · Cited by 166
Molldrem, J. J., Lee, P. P., Wang, C., Champlin, R. E., & Davis, M. M. (1999) · PubMed · Cited by 166
Regulation of the hTERT telomerase catalytic subunit by the c-Abl tyrosine kinase
Kharbanda, S., Kumar, V., Dhar, S., Pandey, P., Chen, C., Majumder, P., Yuan, Z.-M., Whang, Y., Strauss, W., Pandita, T. K., et al. (2000) · Current Biology · doi:10.1016/s0960-9822(00)00483-8 · Cited by 165
Gaiger, A., Henn, T., Horth, E., Geissler, K., Mitterbauer, G., Maier-Dobersberger, T., Greinix, H., Mannhalter, C., Haas, O., & Lechner, K. (1995) · Blood · doi:10.1182/blood.v86.6.2371.bloodjournal8662371 · Cited by 160
IL-3 dependent regulation of Bcl-xL gene expression by STAT5 in a bone marrow derived cell line
Dumon, S., Santos, S. C. R., Debierre-Grockiego, F., Gouilleux-Gruart, V, Cocault, L., Boucheron, C., Mollat, P., Gisselbrecht, S., & Gouilleux, F. (1999) · Oncogene · doi:10.1038/sj.onc.1202796 · Cited by 159
STAT5-Dependent CyclinD1 and Bcl-xL Expression in Bcr-Abl-Transformed Cells
de Groot, R. P., Raaijmakers, J. A. M., Lammers, J. J., & Koenderman, L. (2000) · Molecular Cell Biology Research Communications · doi:10.1006/mcbr.2000.0231 · Cited by 150
Yong, A. S. M., Szydlo, R., Goldman, J. M., Apperley, J. F., & Melo, J. V. (2005) · Blood · doi:10.1182/blood-2005-05-2155 · Cited by 138
Self-citationWnt-signalling pathway in ovarian epithelial tumours: increased expression of β-catenin and GSK3β
Rask, K., Nilsson, A., Brännström, M., Carlsson, P., Hellberg, P., Janson, P. O., Hedin, L., & Sundfeldt, K. (2003) · British Journal of Cancer · doi:10.1038/sj.bjc.6601265 · Cited by 138
Mohty, M., Yong, A. S. M., Szydlo, R., Apperley, J. F., & Melo, J. V. (2007) · Blood · doi:10.1182/blood-2006-12-065599 · Cited by 138
Self-citationTelomere shortening associated with disease evolution patterns in myelodysplastic syndromes.
Ohyashiki, J. H., Ohyashiki, K., Fujimura, T., Kawakubo, K., Shimamoto, T., Iwabuchi, A., & Toyama, K. (1994) · PubMed · Cited by 124
Secondary Mutation Maintains the Transformed State in BaF3 Cells With Inducible BCR/ABL Expression
Klucher, K. M., Lopez, D. V., & Daley, G. Q. (1998) · Blood · doi:10.1182/blood.v91.10.3927 · Cited by 122
Gaymes, T. J., Mufti, G. J., & Rassool, F. V. (2002) · PubMed · Cited by 121
Bentley, J. (2004) · Nucleic Acids Research · doi:10.1093/nar/gkh842 · Cited by 120
Grade, M., Hörmann, P., Becker, S., Hummon, A. B., Wangsa, D., Varma, S., Simon, R., Liersch, T., Heinz Becker, A., Difilippantonio, M. J., et al. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-1514 · Cited by 120
Abnormalities of the retinoblastoma gene in the pathogenesis of acute leukemia
Ahuja, H., Jat, P., Foti, A., Bar‐Eli, M., & Cline, M. (1991) · Blood · doi:10.1182/blood.v78.12.3259.3259 · Cited by 119
BCR/ABL translocates to the nucleus and disrupts an ATR-dependent intra-S phase checkpoint
Dierov, J., Dierova, R., & Carroll, M. (2004) · Cancer Cell · doi:10.1016/s1535-6108(04)00056-x · Cited by 117
Chronic myelogenous leukemia molecular signature
Nowicki, M. O., Pawlowski, P., Fischer, T. H., Heß, G., Pawlowski, T., & Skórski, T. (2003) · Oncogene · doi:10.1038/sj.onc.1206620 · Cited by 114
Cambier, N., Chopra, R., Strasser, A., Metcalf, D., & Elefanty, A. G. (1998) · Oncogene · doi:10.1038/sj.onc.1201490 · Cited by 110
Nucifora, G., Birn, D. J., Espinosa, R., Erickson, P., Beau, M. M. L., Roulston, D., McKeithan, T. W., Drabkin, H. A., & Rowley, J. D. (1993) · PubMed · Cited by 106
Canitrot, Y., Lautier, D., Laurent, G., Fréchet, M., Ahmed, A. A., Turhan, A. G., Salles, B., Cazaux, C., & Hoffmann, J. (1999) · Oncogene · doi:10.1038/sj.onc.1202619 · Cited by 101
Down-regulation of BRCA1 in BCR-ABL–expressing hematopoietic cells
Deutsch, É., Jarrousse, S., Selimoglu‐Buet, D., Dugray, A., Bonnet, M., Vozenin, M., Guilhot, F., Turhan, A. G., Feunteun, J., & Bourhis, J. (2003) · Blood · doi:10.1182/blood-2002-10-3011 · Cited by 100
Gene expression analysis of early and advanced gastric cancers
Vecchi, M., Nuciforo, P. G., Romagnoli, S., Confalonieri, S., Pellegrini, C., Serio, G., Quarto, M., Capra, M. C., Roviaro, G., Avesani, E. C., et al. (2007) · Oncogene · doi:10.1038/sj.onc.1210208 · Cited by 90
Guerzoni, C., Bardini, M., Mariani, S. A., Ferrari‐Amorotti, G., Neviani, P., PANNO, M. L., Zhang, Y., Martinez, R., Perrotti, D., & Calabretta, B. (2006) · Blood · doi:10.1182/blood-2005-08-3181 · Cited by 87
Brady, N., Gaymes, T. J., Cheung, M., Mufti, G. J., & Rassool, F. V. (2003) · PubMed · Cited by 83
Towatari, M., Adachi, K., Kato, H., & Saito, H. (1991) · Blood · doi:10.1182/blood.v78.9.2178.2178 · Cited by 81
BCR/ABL modifies the kinetics and fidelity of DNA double-strand breaks repair in hematopoietic cells
Słupianek, A., Nowicki, M. O., Koptyra, M., & Skórski, T. (2005) · DNA repair · doi:10.1016/j.dnarep.2005.10.005 · Cited by 80
p210 BCR/ABL kinase regulates nucleotide excision repair (NER) and resistance to UV radiation
Canitrot, Y., Falinski, R., Louat, T., Laurent, G., Cazaux, C., Hoffmann, J., Lautier, D., & Skórski, T. (2003) · Blood · doi:10.1182/blood-2002-10-3207 · Cited by 80
The BCR-ABL oncoprotein potentially interacts with the xeroderma pigmentosum group B protein
Takeda, N., Shibuya, M., & Maru, Y. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.1.203 · Cited by 79
Cuenco, G. M., & Ren, R. (2001) · Oncogene · doi:10.1038/sj.onc.1205095 · Cited by 79
Ohmine, K., Ota, J., Ueda, M., Ueno, S., Yoshida, K., Yamashita, Y., Kirito, K., Imagawa, S., Nakamura, Y., Saito, K., et al. (2001) · Oncogene · doi:10.1038/sj.onc.1205029 · Cited by 79
Elmaagacli, A. H., Beelen, D. W., Opalka, B., Seeber, S., & Schaefer, U. (2000) · Annals of Hematology · doi:10.1007/s002770000169 · Cited by 72
Yamamoto, K., Nakamura, Y., Nakamura, Y., Saito, K., & Furusawa, S. (2000) · British Journal of Haematology · doi:10.1046/j.1365-2141.2000.02003.x · Cited by 66
Wagner, K., Zhang, P., Rosenbauer, F., Drescher, B., Kobayashi, S., Radomska, H. S., Kutok, J. L., Gilliland, D. G., Krauter, J., & Tenen, D. G. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0508143103 · Cited by 66
NUP98 gene rearrangements and the clonal evolution of chronic myelogenous leukemia
Ahuja, H. G., Popplewell, L. L., Tcheurekdjian, L., & Slovak, M. L. (2001) · Genes Chromosomes and Cancer · Cited by 63
ATR-Chk1 Axis Protects BCR/ABL Leukemia Cells from the Lethal Effect of DNA Double-Strand Breaks
Nieborowska-Skorska, M., Stokłosa, T., Datta, M., Czechowska, A., Rink, L. A., Słupianek, A., Koptyra, M., Seferyńska, I., Krszyna, K., Błasiak, J., et al. (2006) · Cell Cycle · doi:10.4161/cc.5.9.2722 · Cited by 59
Campbell, L. J., Fidler, C., Eagleton, H., Peniket, A., Kušec, R., Gal, S., Littlewood, T. J., Wainscoat, J. S., & Boultwood, J. (2006) · Leukemia · doi:10.1038/sj.leu.2404141 · Cited by 58
Drummond, M. W., Lennard, A. L., Brümmendorf, T. H., & Holyoake, T. L. (2004) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.1080/10428190410001693542 · Cited by 56
Serra, A., Gottardi, E. M., Ragione, F. D., Saglio, G. N., & Iolascon, A. (1995) · British Journal of Haematology · doi:10.1111/j.1365-2141.1995.tb05358.x · Cited by 55
Considering the cancer consequences of altered DNA polymerase function
Kunkel, T. A. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00027-8 · Cited by 55
Detection of BCR-ABL proteins in blood cells of benign phase chronic myelogenous leukemia patients.
Guo, J., Wang, J., & Arlinghaus, R. B. (1991) · PubMed · Cited by 49
Alterations ofP53andRBGenes and the Evolution of the Accelerated Phase of Chronic Myeloid Leukemia
Beck, Z., Kiss, A., Tóth, F., Szabó, J., Bácsi, A., Balogh, E., Borbély, Á., Telek, B., Kovács, E. M., Oláh, É., et al. (2000) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.3109/10428190009059278 · Cited by 43
Chronic Myeloid Leukemia Blast Crisis Arises from Progenitors
Michor, F. (2007) · Stem Cells · doi:10.1634/stemcells.2006-0638 · Cited by 43
Fujiwara, H., Ouriaghli, F. E., Grube, M., Price, D. A., Rezvani, K., Emma Gostick, D., Sconocchia, G., Melenhorst, J. J., Hensel, N. F., Douek, D. C., et al. (2003) · Blood · doi:10.1182/blood-2003-07-2424 · Cited by 42
Requirement for Mdm2 in the survival effects of Bcr-Abl and interleukin 3 in hematopoietic cells.
Goetz, A. W., van der Kuip, H., Maya, R. B.-Y., Oren, M., & Aulitzky, W. E. (2001) · PubMed · Cited by 39
Huntly, B. J. P., & Gilliland, D. G. (2004) · Cancer Cell · doi:10.1016/j.ccr.2004.09.005 · Cited by 38
Genomic p16 abnormalities in the progression of chronic myeloid leukemia into blast crisis
Hernández‐Boluda, J. C., Cervantes, F., Colomer, D., Vela, M.-C., Costa, D., Paz, M. F., Esteller, M., & Montserrat, E. (2003) · Experimental Hematology · doi:10.1016/s0301-472x(02)01075-5 · Cited by 35
Leukemogenesis induced by wild-type and STI571-resistant BCR/ABL is potently suppressed by C/EBPα
Ferrari‐Amorotti, G., Keeshan, K., Zattoni, M., Guerzoni, C., Iotti, G., Cattelani, S., Donato, N. J., & Calabretta, B. (2006) · Blood · doi:10.1182/blood-2006-01-011833 · Cited by 35
Enhanced expression and activity of DNA polymerase beta in chronic myelogenous leukemia.
Canitrot, Y., Laurent, G., Astarie‐Dequeker, C., Bordier, C., Cazaux, C., & Hoffmann, J. (2006) · PubMed · Cited by 27
Pabst, T., Stillner, E., Neuberg, D. S., Nimer, S. D., Willman, C. L., List, A. F., Melo, J. V., Tenen, D. G., & Mueller, B. U. (2006) · British Journal of Haematology · doi:10.1111/j.1365-2141.2006.06057.x · Cited by 17
Self-citationBrain, J. M., Goodyer, N., & Laneuville, P. (2003) · PubMed · Cited by 16
Dierov, J. K., Schoppy, D. W., & Carroll, M. P. (2005) · Blood · doi:10.1182/blood.v106.11.1989.1989 · Cited by 3
Cited by
BCR–ABL1 lymphoblastic leukaemia is characterized by the deletion of Ikaros
Mullighan, C. G., Miller, C. B., Radtke, I., Phillips, L. A., Dalton, J., Ma, J., White, D., Hughes, T. P., Le Beau, M. M., Pui, C.-H., et al. (2008) · Nature · doi:10.1038/nature06866 · Cited by 1,072
Sustained proliferation in cancer: Mechanisms and novel therapeutic targets
Feitelson, M. A., Arzumanyan, A., Kulathinal, R. J., Blain, S. W., Holcombe, R. F., Mahajna, J., Marino, M., Martinez-Chantar, M. L., Nawroth, R., Sanchez-Garcia, I., et al. (2015) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2015.02.006 · Cited by 778
Molecular biology of bcr-abl1–positive chronic myeloid leukemia
Quintás-Cardama, A., & Cortes, J. (2009) · Blood · doi:10.1182/blood-2008-03-144790 · Cited by 745
The impact of a negligent G2/M checkpoint on genomic instability and cancer induction
Löbrich, M., & Jeggo, P. A. (2007) · Nature Reviews Cancer · doi:10.1038/nrc2248 · Cited by 632
Eiring, A. M., Harb, J. G., Neviani, P., Garton, C., Oaks, J. J., Spizzo, R., Liu, S., Schwind, S., Santhanam, R., Hickey, C. J., et al. (2010) · Cell · doi:10.1016/j.cell.2010.01.007 · Cited by 560
Metadata
- Authors
- Melo, J. V., & Barnes, D. J.
- Venue
- Nature Reviews Cancer
- Published
- 2007-06
- Volume
- 7
- Issue
- 6
- Pages
- 441-453
- ISSN
- 1474-175X (ISSN-L)
- 1474-1768
- OpenAlex
- W2086344594
- Cited by
- 623
- References
- 138
- FWCI
- 3.86
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.